SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POSASR - Post-effective Amendment to an automatic shelf registration statement:
SEC Accession No. 0001193125-23-030001
Filing Date
2023-02-09
Accepted
2023-02-09 16:06:31
Documents
6
Effectiveness Date
2023-02-09

Document Format Files

Seq Description Document Type Size
1 POSASR d448850dposasr.htm POSASR 392807
2 EX-5.1 d448850dex51.htm EX-5.1 34639
3 EX-23.1 d448850dex231.htm EX-23.1 1763
4 EX-FILING FEES d448850dexfilingfees.htm EX-FILING FEES 58788
5 GRAPHIC g448850g0206134215970.jpg GRAPHIC 2640
6 GRAPHIC g448850g0207021940695.jpg GRAPHIC 3993
  Complete submission text file 0001193125-23-030001.txt   498544
Mailing Address 1700 OWENS STREET, SUITE 205 SAN FRANCISCO CA 94158
Business Address 1700 OWENS STREET, SUITE 205 SAN FRANCISCO CA 94158 (415) 660-5320
Nurix Therapeutics, Inc. (Filer) CIK: 0001549595 (see all company filings)

IRS No.: 270838048 | State of Incorp.: DE | Fiscal Year End: 1130
Type: POSASR | Act: 33 | File No.: 333-258448 | Film No.: 23606241
SIC: 2834 Pharmaceutical Preparations